---
document_datetime: 2023-09-21 19:58:34
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/trepulmix-epar-all-authorised-presentations_en.pdf
document_name: trepulmix-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0155421
conversion_datetime: 2025-12-19 23:34:45.94191
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|---------------------------|-------------|
| EU/1/19/1419/001 | Trepulmix         | 1 mg/ml    | Solution for infusion | Subcutaneous use          | Vial                  | 10 mg/10 ml               | 1 vial      |
| EU/1/19/1419/002 | Trepulmix         | 2.5 mg/ml  | Solution for infusion | Subcutaneous use          | Vial                  | 25 mg/10 ml               | 1 vial      |
| EU/1/19/1419/003 | Trepulmix         | 5 mg/ml    | Solution for infusion | Subcutaneous use          | Vial                  | 50 mg/10 ml               | 1 vial      |
| EU/1/19/1419/004 | Trepulmix         | 10 mg/ml   | Solution for infusion | Subcutaneous use          | Vial                  | 100 mg/10 ml              | 1 vial      |